Inflammatory Bowel Disease in Children With Systemic Juvenile Idiopathic Arthritis
Author(s) -
Justine Maller,
Emily Fox,
K.T. Park,
Sarah Sertial Paul,
Kevin Baszis,
Charlotte Borocco,
Sampath Prahalad,
Pierre Quartier,
Adam Reinhardt,
Dieneke SchonenbergMeinema,
Lauren Shipman-Duensing,
Maria Teresa Terreri,
Julia F. Simard,
Idit Lavi,
Elizabeth Chalom,
Joyce Hsu,
Devy Zisman,
Elizabeth Mellins
Publication year - 2020
Publication title -
the journal of rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.577
H-Index - 178
eISSN - 1499-2752
pISSN - 0315-162X
DOI - 10.3899/jrheum.200230
Subject(s) - medicine , inflammatory bowel disease , etanercept , macrophage activation syndrome , arthritis , cohort , population , crohn's disease , disease , immunology , tumor necrosis factor alpha , environmental health
The incidence of inflammatory bowel disease (IBD) in juvenile idiopathic arthritis (JIA) is higher than in the general pediatric population. However, reports of IBD in the systemic JIA (sJIA) subtype are limited. We sought to characterize sJIA patients diagnosed with IBD and to identify potential contributing risk factors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom